EYA4

EYA transcriptional coactivator and phosphatase 4, the group of EYA transcriptional coactivator and phosphatases

Basic information

Region (hg38): 6:133240514-133532128

Previous symbols: [ "DFNA10", "CMD1J" ]

Links

ENSG00000112319NCBI:2070OMIM:603550HGNC:3522Uniprot:O95677AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal dominant nonsyndromic hearing loss 10 (Strong), mode of inheritance: AD
  • autosomal dominant nonsyndromic hearing loss (Supportive), mode of inheritance: AD
  • dilated cardiomyopathy 1J (Supportive), mode of inheritance: AD
  • autosomal dominant nonsyndromic hearing loss 10 (Strong), mode of inheritance: AD
  • nonsyndromic genetic hearing loss (Definitive), mode of inheritance: AD
  • dilated cardiomyopathy 1J (Limited), mode of inheritance: AD
  • autosomal dominant nonsyndromic hearing loss 10 (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cardiomyopathy, dilated, 1JADCardiovascularRelated to cardiomyopathy, preventive measures and medical management may be helpful to help decrease morbidityAudiologic/Otolaryngologic; Cardiovascular10769282; 10982027; 11159937; 15735644; 17568404; 17567890
The condition may also include childhood-onset sensorineural hearing loss

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the EYA4 gene.

  • Dilated_cardiomyopathy_1J (753 variants)
  • Cardiovascular_phenotype (353 variants)
  • not_provided (210 variants)
  • Autosomal_dominant_nonsyndromic_hearing_loss_10 (79 variants)
  • not_specified (69 variants)
  • EYA4-related_disorder (20 variants)
  • Rare_genetic_deafness (3 variants)
  • Hearing_impairment (3 variants)
  • Nonsyndromic_Hearing_Loss,_Dominant (1 variants)
  • Dilated_Cardiomyopathy,_Dominant (1 variants)
  • Congestive_heart_failure (1 variants)
  • Hypertrophic_cardiomyopathy (1 variants)
  • Left_ventricular_noncompaction_cardiomyopathy (1 variants)
  • Inborn_genetic_diseases (1 variants)
  • Nonsyndromic_genetic_hearing_loss (1 variants)
  • Ventricular_tachycardia (1 variants)
  • Primary_familial_hypertrophic_cardiomyopathy (1 variants)
  • Myoepithelial_tumor (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the EYA4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004100.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
199
clinvar
1
clinvar
205
missense
1
clinvar
3
clinvar
469
clinvar
16
clinvar
489
nonsense
19
clinvar
13
clinvar
1
clinvar
33
start loss
2
2
frameshift
22
clinvar
8
clinvar
2
clinvar
32
splice donor/acceptor (+/-2bp)
3
clinvar
13
clinvar
3
clinvar
1
clinvar
20
Total 45 37 482 216 1

Highest pathogenic variant AF is 0.0000266795

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
EYA4protein_codingprotein_codingENST00000367895 19291523
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.04870.9511257360111257470.0000437
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.122763330.8280.00001684153
Missense in Polyphen92135.820.677381741
Synonymous1.381031220.8410.000006681223
Loss of Function4.181037.70.2650.00000173467

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001810.000181
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.00003520.0000352
Middle Eastern0.00005440.0000544
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Tyrosine phosphatase that specifically dephosphorylates 'Tyr-142' of histone H2AX (H2AXY142ph). 'Tyr-142' phosphorylation of histone H2AX plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress. Promotes efficient DNA repair by dephosphorylating H2AX, promoting the recruitment of DNA repair complexes containing MDC1. Its function as histone phosphatase probably explains its role in transcription regulation during organogenesis. May be involved in development of the eye (By similarity). {ECO:0000250|UniProtKB:Q99502}.;
Disease
DISEASE: Cardiomyopathy, dilated 1J (CMD1J) [MIM:605362]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. CMD1J is characterized by the association of sensorineural hearing loss and dilated cardiomyopathy in the absence of other anomalies. {ECO:0000269|PubMed:15735644}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
DNA Repair;DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response (Consensus)

Recessive Scores

pRec
0.160

Intolerance Scores

loftool
0.0973
rvis_EVS
-0.42
rvis_percentile_EVS
25.56

Haploinsufficiency Scores

pHI
0.748
hipred
Y
hipred_score
0.604
ghis
0.552

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.269

Gene Damage Prediction

AllRecessiveDominant
MendelianHighMediumHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Eya4
Phenotype
growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; embryo phenotype; immune system phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype;

Zebrafish Information Network

Gene name
eya4
Affected structure
pillar of the posterior semicircular canal
Phenotype tag
abnormal
Phenotype quality
malformed

Gene ontology

Biological process
DNA repair;multicellular organism development;visual perception;sensory perception of sound;anatomical structure morphogenesis;histone dephosphorylation;peptidyl-tyrosine dephosphorylation;positive regulation of DNA repair;anatomical structure development;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
Cellular component
nucleus;cytoplasm
Molecular function
protein tyrosine phosphatase activity;protein binding;metal ion binding